Cargando…

Kwiatkowski JL, Hamdy M, El-Beshlawy A, et al. Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study. Blood Adv. 2022;6(4):1243-1254.

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2023
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333737/ https://www.ncbi.nlm.nih.gov/pubmed/37368454 http://dx.doi.org/10.1182/bloodadvances.2023009896

Ejemplares similares

Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study
por: Kwiatkowski, Janet L., et al.
Publicado: (2022)

Cardiac and hepatic iron and ejection fraction in thalassemia major: Multicentre prospective comparison of combined Deferiprone and Deferoxamine therapy against Deferiprone or Deferoxamine Monotherapy
por: Pepe, Alessia, et al.
Publicado: (2013)

Chelation Therapy with Oral Solution of Deferiprone in Transfusional Iron-Overloaded Children with Hemoglobinopathies
por: Makis, Alexandros, et al.
Publicado: (2013)

Effects of combined deferiprone with deferoxamine on right ventricular function in thalassaemia major
por: Alpendurada, Francisco, et al.
Publicado: (2012)

Comparison of iron chelation effects of deferoxamine, deferasirox, and combination of deferoxamine and deferiprone on liver and cardiac T2* MRI in thalassemia maior
por: Ansari, Shahla, et al.
Publicado: (2017)

A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease
por: Vichinsky, Elliott, et al.
Publicado: (2007)

Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload
por: Smith, Gillian C, et al.
Publicado: (2011)

Treatment of heart failure in adults with thalassemia major: response in patients randomised to deferoxamine with or without deferiprone
por: Porter, John B, et al.
Publicado: (2013)

Mr Krzysztof Kwiatkowski, President Supreme Audit Office Republic of Poland
por: Brice, Maximilien, et al.
Publicado: (2018)

The safety and acceptability of twice‐daily deferiprone for transfusional iron overload: A multicentre, open‐label, phase 2 study
por: Badawy, Sherif M., et al.
Publicado: (2021)

Deferiprone for transfusional iron overload in sickle cell disease and other anemias: open-label study of up to 3 years
por: Elalfy, Mohsen S., et al.
Publicado: (2022)

Comparative Efficacy and Safety of Deferoxamine, Deferiprone and Deferasirox on Severe Thalassemia: A Meta-Analysis of 16 Randomized Controlled Trials
por: Xia, Sujian, et al.
Publicado: (2013)

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes
por: Taher, Ali T, et al.
Publicado: (2016)

Medicina transfusional
Publicado: (2010)

Medicina transfusional
Publicado: (2006)

Medicina transfusional

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes
por: Kontoghiorghe, Christina N, et al.
Publicado: (2016)

1243. Eravacycline in Bacteremia: A Case Series
por: Andrade, Justin A, et al.
Publicado: (2021)

Medicina transfusional : patient blood management /
Publicado: (2019)

Transfusiones sanguíneas de urgencia
por: López Martínez, Velia
Publicado: (1997)

Manual de medicina transfusional
Publicado: (2005)

Tratado de medicina transfusional perioperatoria
Publicado: (2010)

Aspectos clínicos en medicina transfusional
Publicado: (2004)

Transfusiones de sangre y plasma
por: Marín, Federico
Publicado: (1960)

Tópicos selectos de medicina transfusional /
Publicado: (2002)

Transfusiones sanguíneas riesgos y alternativas.
por: González Isassi, Salvador
Publicado: (1997)

1243. Hepatitis D Virus and Hepatitis B Virus Epidemiology in Utah
por: Hesterman, Matthew, et al.
Publicado: (2022)

Asociación Mexicana de Medicina Transfusional : 10 años /
Publicado: (2012)

La Transfusione del Sangue negli alienati
por: Pouza, G. L.
Publicado: (1875)

Actualización en anemia y terapia transfusional
por: Madrazo-González, Z., et al.
Publicado: (2011)

Salmonella Typhimurium and Pseudomonas aeruginosa Respond Differently to the Fe Chelator Deferiprone and to Some Novel Deferiprone Derivatives
por: Ammendola, Serena, et al.
Publicado: (2021)

Effects of Aroclor 1254 on In Vivo Oocyte Maturation in the Mouse
por: Liu, ShuZhen, et al.
Publicado: (2014)

Molecular differences between two Jeryl Lynn mumps virus vaccine component strains, JL5 and JL2
por: Chambers, Phil, et al.
Publicado: (2009)

Thermus oshimai JL-2 and T. thermophilus JL-18 genome analysis illuminates pathways for carbon, nitrogen, and sulfur cycling
por: Murugapiran, Senthil K., et al.
Publicado: (2013)

Polymake.jl: A New Interface to polymake
por: Kaluba, Marek, et al.
Publicado: (2020)

1243. Comparative Analysis of Antimicrobial-related Adverse Events in the Outpatient Treatment of Staphylococcal Infections
por: Smith, Bradley, et al.
Publicado: (2018)

A Rare Presentation of Transfusional Hemochromatosis: Hypogonadotropic Hypogonadism
por: Ucler, Rifki, et al.
Publicado: (2015)

Defining the noninferiority margin and analysing noninferiority: An overview
por: Althunian, Turki A., et al.
Publicado: (2017)

Effects of Aroclor 1254 on Intestinal Immunity, Metabolism, and Microflora in Zebrafish
por: Zhu, Di-Hua, et al.
Publicado: (2022)

Prospective comparison on cardiac iron by MR in thalassemia major patients treated with combination deferipron-desferrioxamine versus deferipron and desferrioxamine in monoterapy
por: Pepe, Alessia, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_a0f0g7jaetpbs1b749aupp8dts